PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Arnold, Douglas L.
TI  - Treatment with Alemtuzumab Leads to Durable Benefits in Patients with Multiple Sclerosis
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 9--9
VI  - 14
IP  - 6
4099  - http://mdc.sagepub.com/content/14/6/9.1.short
4100  - http://mdc.sagepub.com/content/14/6/9.1.full
AB  - Treatment with alemtuzumab is associated with durable improvements in magnetic resonance imaging (MRI) disease activity in patients with active relapsing-remitting multiple sclerosis. This article presents the 3-year results from An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab (NCT00930553), an ongoing extension study of the Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis (CARE-MS) series of studies.